Life Science evolves.
Donaldson solves.
With decades of global experience in complex manufacturing, Donaldson brings the stability, scale, and expertise to deliver the most innovative technologies for improving human health worldwide. Let's build a problem-solving partnership and develop your best solutions together.
Take the lead with Donaldson.
Our Solutions
Merging decades of expertise with cutting-edge innovation to empower the development of life-saving medications and therapies. Explore our story and commitment to advancing global health.
Explore our Bioprocessing Brands
Reagents that enhance the purity and quality of advanced therapeutics without chromatography.
Membrane chromatography products for rapid, high-volume biologics purification.
Customizable fermentors, bioreactors, and biotech equipment for cutting-edge bioprocessing.
Advanced bioreactors that are designed for each level of scalable biomanufacturing cell culture.
"We continue to expand our product portfolio aimed at providing customers with a comprehensive, differentiated offering as we progress toward a Life Sciences market leadership position and help address urgent human needs."
Tod E. Carpenter, Chief Executive Officer of Donaldson
News
Univercells Technologies by Donaldson Launches scale-X™ nexo Mini Bioreactor
Isolere Bio by Donaldson Launches Research-Grade IsoTag™ AAV Reagent
Donaldson Expands Relationship with Gene Therapy Program at University of Pennsylvania
Donaldson Company Invests in New Life Sciences Technical Center | Donaldson Life Sciences
Donaldson Announces Integrated Lentiviral Vector Manufacturing Platform Development | Donaldson Life Sciences
Donaldson Company Acquires Solaris Biotechnology | Donaldson Life Sciences
Donaldson Acquires Purilogics, Expanding Life Sciences Portfolio | Donaldson Life Sciences
Donaldson Enters into Agreement to Acquire Minority Stake in Medica, S.p.A.
Donaldson Acquires Isolere Bio, Continuing to Build Life Sciences Business
Donaldson Acquires Univercells Technologies, Broadens Life Sciences Reach
